MENTAL ILLNESS AND PSYCHOTROPIC MEDICATION USE IN THE NURSING HOME

Saved in:

ARLING, G., ET AL., MENTAL ILLNESS AND PSYCHOTROPIC MEDICATION USE IN THE NURSING HOME. JOURNAL OF AGING AND HEALTH, Vol. 3, no. 4 (1991), p. 455-472.

Ref. 25713

Location: SIIS R.816 Depósito (106) Archivo

Solicitar documento

Palabras clave:
Confusión, Enfermedades mentales, Fármacos, Personas mayores, Psicótropos, Residencias asistidas

Similar Items: MENTAL ILLNESS AND PSYCHOTROPIC MEDICATION USE IN THE NURSING HOME

Quick Look
BEHAVIORAL REACTIONS TO PSYCHOTROPIC MEDICATION CHANGES FOR NURSING HOME RESIDENTS RECEIVING PSYCHOGERIATRIC PROGRAMMING
Quick Look
PSYCHOTROPIC DRUG PRACTICE IN NURSING HOMES
Quick Look
DEMENTIA AND USE OF PSYCHOTROPIC MEDICATION IN NON-"ELDERLY MENTALLY INFIRM" NURSING HOMES IN SOUTH EAST ENGLAND
Quick Look
LONGITUDINAL STUDY OF PSYCHOTROPIC DRUG USE BY ELDERLY NURSING HOME RESIDENTS
Quick Look
DISCONTINUATION OF A PSYCHOGERIATRIC PROGRAM FOR NURSING HOME RESIDENTS: PSYCHOTROPIC MEDICATION CHANGES AND BEHAVIORAL REACTIONS
Quick Look
GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
Quick Look
NURSING HOME RESOURCES AND TRANQUILIZER USE AMONG THE INSTITUTIONALIZED ELDERLY
Quick Look
CHANGES IN RESIDENT AND FACILITY RISK FACTORS FOR PSYCHOTROPIC DRUG USE IN NURSING HOMES SINCE THE NURSING HOME REFORM ACT
Quick Look
PSYCHOTROPIC MEDICATION FOR ADHD
Quick Look
USE OF PSYCHOTROPIC MEDICATION IN OKLAHOMA: A STATEWIDE SURVEY
Quick Look
RATIONALE OF PSYCHOTROPIC MEDICATIONS IN PALLIATIE CARE
Quick Look
STATEWIDE LONGITUDINAL SURVEY OF PSYCHOTROPIC MEDICATION USE FOR PERSONS WITH MENTAL RETARDATION: 1994 TO 200
Quick Look
USE OF PSYCHOTROPIC MEDICATION IN JUVENILE CORRECTION'S FACILITIES: PRACTICAL CONSIDERATIONS
Quick Look
IMPACT OF INTERDISCIPLINARY TEAM REVIEW ON PSYCHOTROPIC DRUG USE WITH PERSONS WHO HAVE MENTAL RETARDATION
Quick Look
USE OF A REVISED VERSION OF THE PSYCHOTROPIC MEDICATION EFFICACY GRAPH
Quick Look
PSYCHOTROPIC DRUGS AND MENTAL RETARDATION: 1.DISABILITIES AND THE PRESCRIPTION OF DRUGS FOR BEHAVIOUR AND FOR EPILEPSY IN THREE RESIDENTIAL SETTINGS
Quick Look
PSYCHOTROPIC DRUGS AND MENTAL RETARDATION: 1. DISABILITIES AND THE PRESCRIPTION OF DRUGS FOR BEHAVIOUR AND FOR EPILEPSY IN THREE RESIDENTIAL SETTINGS
Quick Look
AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
Quick Look
SUNDOWN SYNDROME: IS IT REFLECTED IN THE USE OF PRN MEDICATIONS FOR NURSING HOME RESIDENTS?
Quick Look
PSYCHOTROPIC DRUGS AND MENTAL RETARDATION: 2.A COMPARISON OF PSYCHOACTIVE DRUG USE BEFORE AND AFTER DISCHARGE FROM HOSPITAL TO COMMUNITY
Quick Look
Tailored interventions for inappropriate psychotropic drug use in nursing home residents with dementia: participatory action research in a special case of a stepped-wedge cluster randomized controlled trial
Quick Look
THE USE OF PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES LIVING IN CANADA
Quick Look
PSYCHOTROPIC MEDICATION USE FOR CHALLENGING BEHAVIORS IN PERSONS WITH INTELLECTUAL DISABILITIES: AN OVERVIEW
Quick Look
Psychotropic drug initiation or increased dosage and the acute risk of falls: a prospective cohort study of nursing home residents